This webinar will discuss performing cervical and breast cancer screening exams in a way that is affirming for LGBTQIA+ patients. We will review patient communication, preparation and completion of the exams, and gender affirming clinical documentation. This session will support health centers in population needs assessment and management, community needs and resource mapping, and clinical effectiveness of care within the population health and social determinants of health domain.
Search Results for: cervical
If You Have It, Check It: Overcoming Barriers to Cervical Cancer Screening with Patients on the Female-to-Male Transgender Spectrum
The majority of FTM transgender individuals retain a cervix and can therefore develop cervical cancer. Because of this, national guidelines recommend that transgender men with a cervix follow the same screening protocol as non-transgender women. However, a recent research study found that Fenway Health patients who identify on the female-to-male (FTM) transgender spectrum have over 10 times higher odds of having an inadequate Papanicolaou (Pap) test compared to female patients. In this webinar, experts in the fields of medicine and research will share primary and secondary cervical cancer prevention strategies and will identify strategies that providers can use to address barriers to optimal screening and prevention in FTM patients.
- Filed under
- Transgender Health
Promoting Cervical Cancer Screening Among Lesbians and Bisexual Women
This Fenway Institute analysis examines the heightened risk profile of lesbians and bisexual women, such as lower rates of health insurance coverage and less access to preventive health care, including routine pelvic exams. It also describes efforts in the UK and Australia to promote Pap tests among lesbians, and why it is important to offer Pap tests to some transgender men, many of whom retain a cervix and may be at risk for cervical cancer. Providers should also be trained in broader LGBT health issues, so that they are equipped to provide clinically competent care to lesbian and bisexual women and transgender men in ways that are sensitive and culturally competent.
- Filed under
- Sexual Minority Women
Anal Dysplasia and Cancer in At-Risk Groups: What Providers Need to Know
Anal cancer is on the rise in the United States. Men who have sex with men (MSM) and HIV-infected people have a higher risk of developing anal cancer compared to the general male population. Although the majority of anal cancers are caused by the human papillomavirus (HPV)--the same virus that causes cervical cancer--there is no official guidance that promotes routine screening for anal cancer. What can health center providers do to prevent anal cancer in their patients? In this webinar, Dr. Lori Panther reviews the basic epidemiology of HPV, and discusses the signs, symptoms, potential screening mechanisms, and prevention methods for anal cancer that providers can offer their patients.
- Filed under
- HIV/STI Treatment and Prevention